Oscient Pharmaceuticals Corporation, a biopharmaceutical company, engages in the clinical development and commercialization of therapeutics to serve medical needs in the United States. Its lead product fluoroquinolone antibiotic FACTIVE tablets are used for the treatment of community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis. The company’s product also comprises Ramoplanin, a Phase II clinical trial completed product, which would be used for the treatment of clostridium difficile-associated disease. Oscient Pharmaceuticals’ preclinical development program includes an oral peptide deformylase inhibitor for the treatment of...
read more
QUOTE
As of 11:54AM EDT May 26, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
Company Details:
| Symbol: |
OSCI |
| SIC: |
-
|
| State location: |
MA |
| Sector: |
- |
| State of Inc: |
MA |
| Employees: |
322 |
| Type: |
NASDAQ |
OSCIENT PHARM (OSCI) MESSAGE BOARD
